000 01761 a2200493 4500
005 20250514065916.0
264 0 _c20030612
008 200306s 0 0 eng d
022 _a0036-5548
024 7 _a10.1080/00365540310000102
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDas, Aditya R
245 0 0 _aA novel thiocationic liposomal formulation of antisense oligonucleotides with activity against Mycobacterium tuberculosis.
_h[electronic resource]
260 _bScandinavian journal of infectious diseases
_c2003
300 _a168-74 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aAntitubercular Agents
_xpharmacology
650 0 4 _aBase Sequence
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aDrug Delivery Systems
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aIsoniazid
_xpharmacology
650 0 4 _aLiposomes
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aModels, Animal
650 0 4 _aMolecular Sequence Data
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aOligonucleotides, Antisense
_xchemistry
650 0 4 _aPharmacogenetics
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aProbability
650 0 4 _aReagent Kits, Diagnostic
650 0 4 _aSensitivity and Specificity
650 0 4 _aTuberculosis, Multidrug-Resistant
_xdrug therapy
700 1 _aDattagupta, Nanibhushan
700 1 _aSridhar, C N
700 1 _aWu, Whei-Kuo
773 0 _tScandinavian journal of infectious diseases
_gvol. 35
_gno. 3
_gp. 168-74
856 4 0 _uhttps://doi.org/10.1080/00365540310000102
_zAvailable from publisher's website
999 _c12539889
_d12539889